Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province 215006, China.
Suzhou Medical College of Soochow University, Suzhou, Jiangsu Province 215002, China.
J Clin Neurosci. 2023 Aug;114:48-54. doi: 10.1016/j.jocn.2023.06.004. Epub 2023 Jun 9.
Tracheostomy is an operative intervention for patients who require ventilator assistance while in the intensive care unit (ICU). This study aimed to compare efficacy and safety between early tracheostomy (ET) and late tracheostomy (LT) in stroke patients.
Embase, PubMed, and the Cochrane Library were searched for available studies. Stroke-related patients were categorized into ET and LT groups using seven days as the cutoff timepoint. The primary efficacy outcome was mortality; secondary efficacy outcomes were modified Rankin Scores (mRS) obtained at follow up, as well as durations of hospital stay, ICU stay, and ventilator use. Safety outcomes were total complication and ventilator associated pneumonia (VAP) incidence.
Nine studies with 3,789 patients were included in the current analysis. No statistical difference in mortality was observed. ET was associated with shorter hospital stay (MD -5.72, 95% CI -9.76 to -1.67), shorter ICU stay (MD -4.77, 95% CI -6.82 to -2.72), and shorter ventilator duration (MD -4.65, 95% CI -8.39 to -0.90); however, no statistically significant difference was found in follow-up mRS scores. Examination of safety measures found the ET group exhibited a lower rate of VAP compared with LT (OR 0.80, 95 % CI 0.68 to 0.93), while no statistical difference was found in total complications.
Our meta-analysis concluded that ET was associated with shorter hospital stay, less time on a ventilator, and lower incidence of VAP. Future studies are warranted to investigate the functional outcomes and the occurrence of complications of ET in stroke patients.
气管切开术是一种针对需要在重症监护病房(ICU)中接受呼吸机辅助治疗的患者的手术干预措施。本研究旨在比较早期气管切开术(ET)和晚期气管切开术(LT)在中风患者中的疗效和安全性。
检索 Embase、PubMed 和 Cochrane Library 以获取可用研究。使用七天作为截止时间点,将中风相关患者分为 ET 和 LT 组。主要疗效结局为死亡率;次要疗效结局为随访时的改良 Rankin 评分(mRS)以及住院时间、ICU 住院时间和呼吸机使用时间。安全性结局为总并发症和呼吸机相关性肺炎(VAP)发生率。
本分析纳入了 9 项研究共 3789 例患者。两组死亡率无统计学差异。ET 组的住院时间(MD-5.72,95%CI-9.76 至-1.67)、ICU 住院时间(MD-4.77,95%CI-6.82 至-2.72)和呼吸机使用时间(MD-4.65,95%CI-8.39 至-0.90)均更短;但随访 mRS 评分无统计学差异。安全性评估发现,ET 组的 VAP 发生率低于 LT 组(OR 0.80,95%CI 0.68 至 0.93),但总并发症发生率无统计学差异。
本荟萃分析得出结论,ET 与缩短住院时间、减少呼吸机使用时间和降低 VAP 发生率有关。需要进一步研究来评估 ET 在中风患者中的功能结局和并发症发生情况。